Health and Fitness Health and Fitness
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
Accuray Incorporated to Speak at 23rd Annual Piper Jaffray Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
NuPathe to Present at the Piper Jaffray 23rd Annual Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Gilead Sciences adquiere Pharmasset, Inc. por 11.000 millones de dlares
[ Tue, Nov 22nd 2011 ] - Market Wire
AmSurg Corp. to Present at the Piper Jaffray 23rd Annual Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Mettler-Toledo International Inc. Announces Webca .. f Presentation at J.P. Morgan SMid Cap Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Cardica Achieves Second Milestone Under Century Distribution Agreement
[ Tue, Nov 22nd 2011 ] - Market Wire
Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Regeneron Announces FDA Acceptance of ARCALYST (r .. lemental Biologics License Application for Review
[ Tue, Nov 22nd 2011 ] - Market Wire
Medtronic Receives FDA Approval for Next Generation Professional Continuous Glucose Monitoring
[ Tue, Nov 22nd 2011 ] - Market Wire
Major U.S. Study Reveals Real-Time Continuous Glu .. se Monitoring Improves Control of Type 2 Diabetes
[ Tue, Nov 22nd 2011 ] - Market Wire
Recent News Stories Highlight Stellar Biotechnologies
[ Tue, Nov 22nd 2011 ] - Market Wire
Prana Receives Approval for Alzheimer's Trial
[ Tue, Nov 22nd 2011 ] - Market Wire
Direction of Market Influences - Report Highlights Inhibitex, Inc. and Invesco Ltd.
[ Tue, Nov 22nd 2011 ] - Market Wire
Sirona Biochem's French Subsidiary Receives CDN$1.9-Million Grant for Cosmeceutical Project
[ Tue, Nov 22nd 2011 ] - Market Wire
Daxor Announces That Harborview Medical Center of .. eattle, WA Acquires BVA-100 Blood Volume Analyzer
[ Tue, Nov 22nd 2011 ] - Market Wire
NxStage Enhances Patient Awareness Efforts with L .. Directory To Help Patients Connect with Local Sys
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
[ Tue, Nov 22nd 2011 ] - Market Wire
EnteroMedics to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
ONE Bio Releases Third Quarter 2011 Results
[ Tue, Nov 22nd 2011 ] - Market Wire
Peregrine Reports Promising 23.2 Month Median Ove .. rvival From Phase II Advanced Breast Cancer Trial
[ Tue, Nov 22nd 2011 ] - Market Wire
Equity Research on Pfizer Inc. and Bristol-Myers .. acturers Focus on R&;;D and Emerging Ma
[ Tue, Nov 22nd 2011 ] - Market Wire
MethylGene to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals
[ Tue, Nov 22nd 2011 ] - Market Wire
Pfizer to Acquire Excaliard Pharmaceuticals
[ Tue, Nov 22nd 2011 ] - Market Wire
Spectranetics to Present at the 23rd Annual Piper Jaffray Healthcare Conference on November 29
[ Tue, Nov 22nd 2011 ] - Market Wire
MELA Sciences to Present at Piper Jaffray 23rd Annual Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Pacira Pharmaceuticals, Inc. Announces Completion .. ommon Stock and Exercise of Over-Allotment Option
[ Tue, Nov 22nd 2011 ] - Market Wire
PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
[ Tue, Nov 22nd 2011 ] - Market Wire
Lexicon Announces Commencement of Rights Offering to Stockholders
[ Tue, Nov 22nd 2011 ] - Market Wire
Astex Pharmaceuticals to Present at Piper Jaffray Health Care Conference on November 29th

Astex Pharmaceuticals to Present at Piper Jaffray Health Care Conference on November 29th


Published on 2011-11-22 03:21:58 - Market Wire
  Print publication without navigation


DUBLIN, Calif.--([ ])--Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel therapeutics, today announced that James S.J. Manuso, Ph.D., chairman and chief executive officer, and Mohammad Azab, M.D., chief medical officer, will present at the 23rd Annual Piper Jaffray Health Care Conference on Tuesday, November 29th in New York.

The Company's presentation will begin at 8:10 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's website, [ www.astx.com ]. The webcast will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals, formerly SuperGen, developed Dacogen (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit [ http://www.astx.com ].

Contributing Sources